Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

While most patients with follicular lymphoma (FL) have excellent outcomes with frontline chemoimmunotherapy (CIT), a subset of patients will experience early progression, which is associated with poor subsequent outcomes. Novel biomarkers are needed to identify high-risk patients earlier. We hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Merryman, Reid W., Michaud, Laure, Redd, Robert, Mondello, Patrizia, Park, Hyesun, Spilberg, Gabriela, Robertson, Matthew, Taranto, Eleanor, Ahmed, Gulrayz, Chase, Matthew, Jeter, Erin, Ahn, Inhye E., Brown, Jennifer R., Crombie, Jennifer, Davids, Matthew S., Fisher, David C., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Ng, Samuel Y., Odejide, Oreofe O., Parry, Erin M., Salles, Gilles, Zelenetz, Andrew D., Armand, Philippe, Schöder, Heiko, Jacene, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875968/
https://www.ncbi.nlm.nih.gov/pubmed/36713355
http://dx.doi.org/10.1097/HS9.0000000000000826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875968/
https://www.ncbi.nlm.nih.gov/pubmed/36713355
http://dx.doi.org/10.1097/HS9.0000000000000826

Ejemplares similares